CIK 0001788028
- Non-accelerated filer
- Smaller reporting company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842984849
- Phone
- +1 650-549-1400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-04 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-02-13 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-06-07 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award | +400 | $4.17 | $2K | 400 |
| 2024-02-15 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2023-06-12 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 |
Page 1 of 1 · 5 trades